CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Clinical trials for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less radiation be better for HPV throat cancer? new trial aims to find out
Disease control Recruiting nowThis study is for people with early-stage HPV-related throat cancer. It tests whether giving a lower dose of radiation to the lymph nodes in the neck that are not directly affected by the cancer can maintain high cure rates while reducing side effects. About 100 participants will…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 16, 2026 20:50 UTC
-
Blood test may allow safer, Lower-Dose radiation for throat cancer patients
Disease control Recruiting nowThis study tests whether a blood test that detects HPV DNA can guide doctors to safely use a lower dose of radiation for people with HPV-related throat cancer. About 45 adults with early-stage HPV-positive oropharyngeal cancer will receive radiation and chemotherapy. The goal is …
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 08, 2026 13:11 UTC
-
Blood test could Fine-Tune radiation for throat cancer patients
Disease control Recruiting nowThis study tests whether a blood test (NavDx) can help doctors choose the right amount of radiation for people with HPV-related throat cancer. The goal is to give enough treatment to stop the cancer from coming back, but not so much that it causes severe side effects. About 455 a…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC
-
New drug aims to prevent painful mouth sores in head and neck cancer treatment
Symptom relief Recruiting nowThis study tests whether adding BMX-001 to standard care can reduce severe mouth sores caused by chemoradiation in head and neck cancer patients. About 98 participants will receive either BMX-001 or a placebo alongside usual mouth rinses and pain medications. The goal is to impro…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC
-
New imaging study reveals hidden vascular damage from radiation therapy
Knowledge-focused Recruiting nowThis study looks at how radiation therapy for head and neck cancers affects blood vessels in the neck. Researchers will use special PET/CT scans to compare two imaging methods. About 20 adults with certain head and neck cancers will take part. The goal is to better understand rad…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:29 UTC
-
Can a simple exercise prevent swallowing problems? study seeks answers.
Knowledge-focused Recruiting nowThis study looks at why some head and neck cancer patients stick with swallowing exercises after radiation, while others don't. Researchers will use blood tests and questionnaires to explore how immune proteins, emotions, and social support affect a patient's ability to follow th…
Matched conditions: CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:27 UTC